These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13981737)

  • 21. Interactions of monoamine oxidase inhibitors and reserpine: an EEG, gross behavioral and biochemical analysis.
    Bueno JR; Pscheidt GR; Himwich HE
    Psychopharmacologia; 1968; 12(5):400-13. PubMed ID: 5723187
    [No Abstract]   [Full Text] [Related]  

  • 22. ANTI-DEPRESSANT DRUGS.
    JACKSON D; BERNARD LA; BENTLIF P
    Med Rec Ann; 1963 Oct; 56():216-8 PASSIM. PubMed ID: 14053455
    [No Abstract]   [Full Text] [Related]  

  • 23. RESERPINE-RESISTENT UPTAKE MECHANISMS OF NORADRENALINE IN TISSUES.
    ANDEN NE; CARLSSON A; WALDECK B
    Life Sci (1962); 1963 Dec; 12():889-94. PubMed ID: 14100218
    [No Abstract]   [Full Text] [Related]  

  • 24. [NEW CONCEPTS IN THE TREATMENT OF RHEUMATOID ARTHRITIS].
    ATDJIAN M; MACKENZIE AH; SCHERBEL AL
    Prensa Med Argent; 1963 Feb; 50():432-6. PubMed ID: 14064380
    [No Abstract]   [Full Text] [Related]  

  • 25. THE CUMULATIVE NATURE OF THE RESERPINE EFFECT AND THE POSSIBILITIES OF INHIBITING CUMULATION PHARMACOLOGICALLY.
    KNOLL J; KNOLL B
    Arch Int Pharmacodyn Ther; 1964 Mar; 148():200-16. PubMed ID: 14171749
    [No Abstract]   [Full Text] [Related]  

  • 26. Direct measurement of monoamine oxidase inhibition in humans.
    LEVINE RJ; SJOERDSMA A
    Clin Pharmacol Ther; 1963; 4():22-7. PubMed ID: 13930166
    [No Abstract]   [Full Text] [Related]  

  • 27. POTENTIATION OF THE ANTI-RESERPINE EFFECTS OF DIHYDROXYPHENYLALANINE BY ANTIDEPRESSANTS AND STIMULANTS.
    MCGRATH WR; KETTELER HJ
    Nature; 1963 Aug; 199():917-8. PubMed ID: 14079911
    [No Abstract]   [Full Text] [Related]  

  • 28. Analgesic effect of some monoamine oxidase inhibitors.
    Jauhari AC; Bapat SK
    Indian J Physiol Pharmacol; 1971 Jan; 15(1):21-6. PubMed ID: 5122772
    [No Abstract]   [Full Text] [Related]  

  • 29. A basis for the use of monoamine oxidase inhibitors in angina pectoris.
    HORWITZ D; SJOERDSMA A
    Ann N Y Acad Sci; 1963 Jul; 107():1033-44. PubMed ID: 13964099
    [No Abstract]   [Full Text] [Related]  

  • 30. Restoration of tyramine responses by bretylium, BW392C60, bethanidine and monoamine oxidase inhibitors in reserpine-treated rats.
    Clarke DE
    Br J Pharmacol; 1970 Jan; 38(1):1-11. PubMed ID: 4391732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anomalous actions of monoamine oxidase inhibitors.
    PSCHEIDT GR
    Ann N Y Acad Sci; 1963 Jul; 107():1057-67. PubMed ID: 13972407
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of the reserpine effect on rat salivary gland noradrenaline by inhibitors of monoamine oxidase and catechol-O-methyl transferase.
    Jonason J
    J Pharm Pharmacol; 1970 Feb; 22(2):93-5. PubMed ID: 4392262
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 34. [Severe migraine, monoamine oxidase inhibitors and methysergide].
    PERRAULT M
    Prog Med (Paris); 1963 Jun; 91():413-22. PubMed ID: 13942540
    [No Abstract]   [Full Text] [Related]  

  • 35. [DRUGS ACTING ON THE NERVOUS SYSTEM. (2). WITH SPECIAL REFERENCE TO TRANQUILIZERS AND ANTIDEPRESSIVE AGENTS].
    FUKUCHI G
    Chiryo; 1963; 45():2255-60. PubMed ID: 14103593
    [No Abstract]   [Full Text] [Related]  

  • 36. [Monoamine oxidase inhibitors as pharmaceutical agents].
    Cherkes OI; Chekman IS
    Farm Zh; 1969; 24(1):10-4. PubMed ID: 4389639
    [No Abstract]   [Full Text] [Related]  

  • 37. Sleep, natural and unnatural.
    Oswald I
    Proc R Soc Med; 1969 Sep; 62(9):901-3. PubMed ID: 4310658
    [No Abstract]   [Full Text] [Related]  

  • 38. [Notes on the treatment of angina pectoris with a new monoamine oxidase inhibitor (M.A.O.I.)].
    GRILLIAT JP; ANTOINE F; SAPELIER P; RASPILLER A
    Ann Med Nancy; 1962 Sep; 1():453-62. PubMed ID: 13950479
    [No Abstract]   [Full Text] [Related]  

  • 39. [ELECTROENCEPHALOGRAPHIC REPORTS IN AGED SUBJECTS TREATED WITH DRUGS WITH AN MONOAMINE OXIDASE INHIBITOR ACTION (NIALAMIDE)].
    SAVOLDI F; COSI V; TAMMARO AE
    G Gerontol; 1964 Sep; 12():1109-13. PubMed ID: 14258420
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of nialamide on adrenergic functions.
    DAVEY MJ; FARMER JB; REINERT H
    Br J Pharmacol Chemother; 1963 Feb; 20(1):121-34. PubMed ID: 14025282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.